Inhalant use and inhalant use disorders in the United States
about
Predictors of substance use among vulnerable adolescents in five cities: findings from the well-being of adolescents in vulnerable environments studySarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in miceReview of toluene action: clinical evidence, animal studies and molecular targets.The role of first use of inhalants within sequencing pattern of first use of drugs among Brazilian university students.Patterns of Inhalant Use among Incarcerated Youth.Patterns of substance use, delinquency, and risk factors among adolescent inhalant users.Drug Use among Street Children in Tehran, Iran: A Qualitative Study.Inhalant abuse: An exploratory study.Binge toluene exposure in pregnancy and pre-weaning developmental consequences in ratsA descriptive study of clinical, hematological, and biochemical parameters of inhalant users seeking treatment at a tertiary care center in India.Prenatal Exposure to Paint Thinner Alters Postnatal Development and Behavior in MicePersistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.Decreased Hippocampal Neuroplasticity and Behavioral Impairment in an Animal Model of Inhalant Abuse.Prenatal toluene exposure impairs performance in the Morris Water Maze in adolescent rats.Inhalant use in adolescents in northern Russia.
P2860
Q27310367-6D936FD5-F0C3-440D-AA46-B44C493B9720Q30528784-0092AC46-27F8-4BB4-964B-8E1621F1F959Q34413651-1155C40D-855B-45CF-8A0C-E56AB3CB0400Q34602792-EA1BD5CC-DF8A-4376-8DCB-A4598D2AB806Q35762649-EC40EABD-C913-4CB9-B830-C1475AED7A82Q36395294-62FBF08D-7275-4AAE-8564-BEA5AE48B0FEQ36396497-0A66B3C1-C440-4005-940A-5ADC2720A693Q36488957-9A79D8DD-24D1-4E66-A8B5-5C0EC247EF0EQ37018383-92A7387A-08AD-4C43-A31A-F1E66941907DQ37176848-DEAC9734-A81E-4865-BAAF-99567F85BF82Q41672912-45B906D9-9642-4FBE-AF3F-F2C369380661Q48190211-A0202A01-2CF5-40DF-9703-651D08B408FFQ50192097-25F41D69-7288-4657-B341-0246E35F6BBDQ50567352-AFB17C94-B16A-4122-ACFF-FE3A6FF8CC11Q55363677-C9F8539B-DCEA-4BC8-AEDD-F2359DC1FF50
P2860
Inhalant use and inhalant use disorders in the United States
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Inhalant use and inhalant use disorders in the United States
@ast
Inhalant use and inhalant use disorders in the United States
@en
Inhalant use and inhalant use disorders in the United States
@nl
type
label
Inhalant use and inhalant use disorders in the United States
@ast
Inhalant use and inhalant use disorders in the United States
@en
Inhalant use and inhalant use disorders in the United States
@nl
prefLabel
Inhalant use and inhalant use disorders in the United States
@ast
Inhalant use and inhalant use disorders in the United States
@en
Inhalant use and inhalant use disorders in the United States
@nl
P2093
P2860
P1476
Inhalant use and inhalant use disorders in the United States
@en
P2093
Brian E Perron
Eric L Garland
Matthew O Howard
Michael G Vaughn
Scott E Bowen
P2860
P407
P577
2011-07-01T00:00:00Z